Julian Kretz
Technical University of Berlin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julian Kretz.
Nature Chemical Biology | 2015
Stéphane Cociancich; Alexander Pesic; Daniel Petras; Stefanie Uhlmann; Julian Kretz; Vivien Schubert; Laura Vieweg; Sandrine Duplan; Mélanie Marguerettaz; Julie Noëll; Isabelle Pieretti; Manuela Hügelland; Sebastian Kemper; Andi Mainz; Philippe Rott; Monique Royer; Roderich D. Süssmuth
Albicidin is a potent DNA gyrase inhibitor produced by the sugarcane pathogenic bacterium Xanthomonas albilineans. Here we report the elucidation of the hitherto unknown structure of albicidin, revealing a unique polyaromatic oligopeptide mainly composed of p-aminobenzoic acids. In vitro studies provide further insights into the biosynthetic machinery of albicidin. These findings will enable structural investigations on the inhibition mechanism of albicidin and its assessment as a highly effective antibacterial drug.
Angewandte Chemie | 2015
Julian Kretz; Dennis Kerwat; Vivien Schubert; Stefan Grätz; Alexander Pesic; Siamak Semsary; Stéphane Cociancich; Monique Royer; Roderich D. Süssmuth
The peptide antibiotic albicidin, which is synthesized by the plant pathogenic bacterium Xanthomonas albilineans, displays remarkable antibacterial activity against various Gram-positive and Gram-negative microorganisms. The low amounts of albicidin obtainable from the producing organism or through heterologous expression are limiting factors in providing sufficient material for bioactivity profiling and structure-activity studies. Therefore, we developed a convergent total synthesis route toward albicidin. The unexpectedly difficult formation of amide bonds between the aromatic amino acids was achieved through a triphosgene-mediated coupling strategy. The herein presented synthesis of albicidin confirms the previously determined chemical structure and underlines the extraordinary antibacterial activity of this compound. The synthetic protocol will provide multigram amounts of albicidin for further profiling of its drug properties.
Chemistry & Biology | 2013
Joanna M. Krawczyk; Ginka H. Völler; Bartlomiej Krawczyk; Julian Kretz; Mark Brönstrup; Roderich D. Süssmuth
Labyrinthopeptins are class III lantibiotics produced by the actinomycete Actinomadura namibiensis. The most characteristic structural feature is the posttranslationally installed triamino triacid labionin with a quaternary α-carbon. In addition to the unique structure, labyrinthopeptin A2 possess remarkable antiviral and antiallodynic biological activities. To harness the substrate tolerance of the biosynthetic machinery, we developed an efficient system for the generation of labyrinthopeptin analogs. Streptomyces lividans was used as a heterologous host since the natural producer Actinomadura namibiensis remained genetically intractable. Generation of a library of 39 mutants allowed identification of variable and invariable regions in the labyrinthopeptin structures. Additional data on the flexibility of the biosynthetic machinery were provided by in vitro experiments. This study is detailed investigation on the potential to generate analogs of class III lantibiotics by genetic engineering.
ChemMedChem | 2016
Stefan Grätz; Dennis Kerwat; Julian Kretz; Leonard von Eckardstein; Siamak Semsary; Maria Seidel; Maria Kunert; John B. Weston; Roderich D. Süssmuth
To investigate the pharmacophore regions of the antibiotic albicidin, derivatives with variations on the central amino acid were synthesized. Charged as well as uncharged residues were chosen to explore the influence of charge, chirality, and steric bulk. The bioactivity of the newly synthesized derivatives was determined by a microdilution technique to obtain minimum inhibitory concentrations (MIC) values. The compounds were also tested in a cell‐free system to obtain information about their ability to inhibit their primary target, DNA gyrase. It was then shown that derivatives with uncharged side chains retain antibacterial activity, whereas incorporation of charged amino acid residues decreases the antibacterial activity dramatically, possibly due to restricted cell penetration of these derivatives. From the newly synthesized derivatives, the threonine derivative shows the most promising results in both tests. The information will help to develop the features of albicidin toward more drug‐like structures.
ChemMedChem | 2016
Dennis Kerwat; Stefan Grätz; Julian Kretz; Maria Seidel; Maria Kunert; John B. Weston; Roderich D. Süssmuth
The peptide antibiotic albicidin, which is synthesized by the plant pathogenic bacterium, Xanthomonas albilineans, represents the most prominent member of a new class of antibacterial gyrase inhibitors. It shows remarkable antibacterial activities against Gram‐positive and Gram‐negative microorganisms. Its unique structure potentially represents a new lead structure for the development of an antibacterial drug. Here we report the synthesis of 14 albicidin derivatives with structural variations at the N‐terminus, primarily investigating the effects of variation of cinnamoyl, phenylpropanoyl, and benzoyl residues. Gyrase inhibition in vitro and determination of minimal inhibitory concentrations were assessed in parallel. Activities in a nanomolar range and the importance of N‐acylation were demonstrated.
Journal of the American Chemical Society | 2015
Laura Vieweg; Julian Kretz; Alexander Pesic; Dennis Kerwat; Stefan Grätz; Monique Royer; Stéphane Cociancich; Andi Mainz; Roderich D. Süssmuth
The para-aminobenzoic acid-containing peptide albicidin is a pathogenicity factor synthesized by Xanthomonas albilineans in infections of sugar cane. Albicidin is a nanomolar inhibitor of the bacterial DNA gyrase with a strong activity against various Gram-negative bacteria. The bacterium Pantoea dispersa expresses the hydrolase AlbD, conferring natural resistance against albicidin. We show that AlbD is a novel type of endopeptidase that catalyzes the cleavage of albicidin at a peptide backbone amide bond, thus abolishing its antimicrobial activity. Additionally, we determined the minimal cleavage motif of AlbD with substrates derived by chemical synthesis. Our results clearly identify AlbD as a unique endopeptidase that is the first member of a new subfamily of peptidases. Our findings provide the molecular basis for a natural detoxification mechanism, potentially rendering a new tool in biological chemistry approaches.
Angewandte Chemie | 2015
Julian Kretz; Dennis Kerwat; Vivien Schubert; Stefan Grätz; Alexander Pesic; Siamak Semsary; Stéphane Cociancich; Monique Royer; Roderich D. Süssmuth
Towards an integrated view of AMP diversity, functions and applications | 2016
Stéphane Cociancich; Alexander Pesic; Daniel Petras; Sandrine Duplan; Benjamin Hempel; Manuela Hügelland; Sebastien Kemper; Dennis Kerwat; Julian Kretz; Andi Mainz; Mélanie Marguerettaz; Julie Noëll; Isabelle Pieretti; Vivien Schubert; Siamak Semsary; Stefanie Uhlmann; Laura Vieweg; Leonard von Eckardstein; Philippe Rott; Monique Royer; Roderich Süssmuth
ChemMedChem | 2016
Stefan Grätz; Dennis Kerwat; Julian Kretz; Leonard von Eckardstein; Siamak Semsary; Maria Seidel; Maria Kunert; John B. Weston; Roderich D. Süssmuth
Archive | 2015
Stéphane Cociancich; Alexander Pesic; Daniel Petras; Stefanie Uhlmann; Julian Kretz; Vivien Schubert; Laura Vieweg; Sandrine Duplan; Mélanie Marguerettaz; Julie Noëll; Isabelle Pieretti; Manuela Hügelland; Sebastien Kemper; Andi Mainz; Philippe Rott; Monique Royer; Roderich Süssmuth